International Clinical Trial: Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813507) titled 'Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: None (Open Label).

Primary Sponsor: University of Calgary

Condition: Critical Illness

Intervention: Dietary Supplement: Synbiotic

Recruitment Status: Not recruiting

Phase: Phase 1/Phase 2

Date of First Enrollment: January 2027

Target Sample Size: 64

Countries of Recruitment: Canada

To know more, visit https://clinicaltrials.gov/study/NCT07813507

Published by H...